These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16793998)

  • 1. A CAP on antibiotic duration.
    Wunderink RG
    Am J Respir Crit Care Med; 2006 Jul; 174(1):3-5. PubMed ID: 16793998
    [No Abstract]   [Full Text] [Related]  

  • 2. How to reduce antibiotic consumption for community-acquired pneumonia?
    Montassier E; Goffinet N; Potel G; Batard E
    Med Mal Infect; 2013 Feb; 43(2):52-9. PubMed ID: 23433607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A procalcitonin-guided algorithm for pneumonia may reduce antibiotic use and treatment duration].
    Berg P; Lindhardt BØ
    Ugeskr Laeger; 2012 Aug; 174(35):1986-9. PubMed ID: 22929575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-acquired pneumonia: judicious use of antibiotics or treatment failure?
    Behere S; Garber MD
    Hosp Pediatr; 2013 Apr; 3(2):180-1. PubMed ID: 24340421
    [No Abstract]   [Full Text] [Related]  

  • 5. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.
    Long W; Deng X; Zhang Y; Lu G; Xie J; Tang J
    Respirology; 2011 Jul; 16(5):819-24. PubMed ID: 21507143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.
    Christ-Crain M; Stolz D; Bingisser R; Müller C; Miedinger D; Huber PR; Zimmerli W; Harbarth S; Tamm M; Müller B
    Am J Respir Crit Care Med; 2006 Jul; 174(1):84-93. PubMed ID: 16603606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum procalcitonin levels and empirical antibiotic treatment of patients with community-acquired febrile syndromes.
    Villanueva JL; Cervin RJ
    Clin Infect Dis; 2003 Mar; 36(6):822; author reply 826-7. PubMed ID: 12627370
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.
    Perren A; Cerutti B; Lepori M; Senn V; Capelli B; Duchini F; Domenighetti G
    Infection; 2008 Mar; 36(2):163-6. PubMed ID: 18330505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of serum procalcitonin in treatment of community acquired pneumonia in outpatient].
    Long W; Deng XQ; Tang JG; Xie J; Zhang YC; Zhang Y; Gao YY; Lu G
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):216-9. PubMed ID: 19576090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin-based guidelines and lower respiratory tract infections.
    Stijnis C; van Nieuwkoop C; van Dissel JT
    JAMA; 2010 Feb; 303(5):418-9; author reply 419-20. PubMed ID: 20124533
    [No Abstract]   [Full Text] [Related]  

  • 11. Empiric antimicrobial therapy of community-acquired pneumonia: clinical diagnosis versus procalcitonin levels.
    Cunha BA
    Scand J Infect Dis; 2009; 41(10):782-4. PubMed ID: 19681019
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk stratification of community-acquired pneumonia: what does all of this mean?
    Jones AE; Kline JA
    Ann Emerg Med; 2008 Jul; 52(1):61-2. PubMed ID: 18387703
    [No Abstract]   [Full Text] [Related]  

  • 13. Pleural Effusion Increases Serum Procalcitonin Values in Children with Community-acquired Pneumonia.
    Fonseca TS; Gendrel D; Ruuskanen O; Nascimento-Carvalho CM
    Pediatr Infect Dis J; 2015 Aug; 34(8):914-5. PubMed ID: 26020411
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum procalcitonin level: clinical significance.
    Aggarwal D; Mohapatra PR; Aggarwal P
    Eur Respir J; 2011 Mar; 37(3):723; author reply 723. PubMed ID: 21357930
    [No Abstract]   [Full Text] [Related]  

  • 15. [Utility of serum procalcitonin as a diagnostic guide in children with community-acquired pneumonia].
    García-Zarza Martínez E; Ramos Amador JT; Rubio Gribble B; Corrales del Río E; Zeballos Sarrato G; Herrera Montes J
    An Pediatr (Barc); 2004 Mar; 60(3):279-81. PubMed ID: 14987523
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood.
    Don M; Valent F; Korppi M; Falleti E; De Candia A; Fasoli L; Tenore A; Canciani M
    Scand J Infect Dis; 2007; 39(2):129-37. PubMed ID: 17366029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Duration of antibiotic therapy in intraabdominal infections].
    Maseda E; Gilsanz F
    Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():49-52. PubMed ID: 21130930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing the right combination therapy in severe community-acquired pneumonia.
    Waterer GW; Rello J
    Crit Care; 2006 Feb; 10(1):115. PubMed ID: 16469123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.
    Masiá M; Gutiérrez F; Shum C; Padilla S; Navarro JC; Flores E; Hernández I
    Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia.
    Cunha BA
    Am J Med; 2001 Oct; 111(5):412-3. PubMed ID: 11583649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.